Thrivent Financial for Lutherans Has $60.28 Million Stake in Corteva, Inc. (NYSE:CTVA)

Thrivent Financial for Lutherans grew its holdings in Corteva, Inc. (NYSE:CTVA) by 16.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,025,266 shares of the company’s stock after purchasing an additional 141,898 shares during the period. Thrivent Financial for Lutherans owned about 0.15% of Corteva worth $60,275,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Acadian Asset Management LLC bought a new stake in shares of Corteva in the 1st quarter valued at approximately $25,000. Capital Advisors Ltd. LLC grew its stake in shares of Corteva by 44.4% in the 3rd quarter. Capital Advisors Ltd. LLC now owns 566 shares of the company’s stock valued at $33,000 after buying an additional 174 shares in the last quarter. Cultivar Capital Inc. bought a new stake in shares of Corteva in the 2nd quarter valued at approximately $34,000. Redwood Wealth Management Group LLC bought a new stake in shares of Corteva in the 2nd quarter valued at approximately $43,000. Finally, Triad Wealth Partners LLC bought a new stake in shares of Corteva in the 2nd quarter valued at approximately $45,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on CTVA. Oppenheimer reaffirmed an “outperform” rating and set a $70.00 target price (up previously from $69.00) on shares of Corteva in a research report on Friday, November 8th. Argus lowered Corteva from a “buy” rating to a “hold” rating in a research note on Wednesday, August 7th. Morgan Stanley reaffirmed an “overweight” rating and issued a $65.00 price target on shares of Corteva in a report on Tuesday, September 24th. Bank of America upgraded Corteva from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $59.00 to $67.00 in a research report on Wednesday, October 16th. Finally, Wells Fargo & Company decreased their target price on Corteva from $67.00 to $65.00 and set an “overweight” rating for the company in a research report on Friday, August 2nd. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $63.68.

Corteva Trading Up 3.3 %

NYSE CTVA opened at $57.01 on Tuesday. The stock has a market capitalization of $39.18 billion, a price-to-earnings ratio of 57.59, a PEG ratio of 1.77 and a beta of 0.77. The stock’s 50 day moving average price is $58.36 and its two-hundred day moving average price is $55.69. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.96 and a current ratio of 1.50. Corteva, Inc. has a 52 week low of $43.89 and a 52 week high of $63.75.

Corteva Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 16th. Stockholders of record on Monday, December 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.19%. The ex-dividend date is Monday, December 2nd. Corteva’s dividend payout ratio is currently 68.69%.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.